| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | RADIUS HEALTH | 3,887,502 | 210,275,000 | 68.88% | ||
| 2 | Syndax Pharmaceuticals Inc | 2,168,691 | 32,877,000 | 10.77% | ||
| 3 | EPIZYME INC COM | 1,729,674 | 17,020,000 | 5.58% | ||
| 4 | CHIASMA INC | 5,736,296 | 16,865,000 | 5.52% | ||
| 5 | ENDOLOGIX INC | 1,121,447 | 14,355,000 | 4.70% | ||
| 6 | Proteon Therapeutics | 983,381 | 9,175,000 | 3.01% | ||
| 7 | CONATUS PHARMACEUTICALS INC COM | 1,192,080 | 2,384,000 | 0.78% | ||
| 8 | ARATANA THERAPEUTICS INC COM | 250,000 | 2,340,000 | 0.77% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-021719, filed 2016.11.10).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
